Chimeric Therapeutics
Business Services · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
62 Lygon St L 3, Carlton, Victoria, 3053...Phone Number
+61 398245254Website
www.chimerictherapeutics.comRevenue
<$5 MillionStock Symbol
CHMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Chimeric Therapeutics
Chimeric Therapeutics, founded in 2020 and based in Carlton, Australia, is a biotechnology company specializing in research and development of innovative cancer treatments. The company focuses on advancing novel therapeutic solutions through clinical trials and scientific research to address unmet medical needs in oncology. Chimeric Therapeutics operates primarily in the business services and research and development sectors, collaborating with healthcare institutions to develop its cancer treatment portfolio.Explore more
Chimeric Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Chimeric Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Chimeric Therapeutics is spiking on competitors!
Check if Chimeric Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Chimeric Therapeutics launches new products
Earning: See what the market has to say on Chimeric Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Chimeric Therapeutics
Click to see if Chimeric Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Chimeric Therapeutics has new funding data
Chimeric Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Chimeric Therapeutics
Find more new buyers
Compare Similar Companies to Chimeric Therapeutics
Compare insights from companies similar to Chimeric Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Chimeric Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Chimeric Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Chimeric Therapeutics.
Chimeric Therapeutics financials insights
Gather financial insights about Chimeric Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$35M
2023
Share Placement
$10.1M
2025
Stock/Share Issuance
$8.4M
Chimeric Therapeutics Tech Stack
A closer look at the technologies used by Chimeric Therapeutics
Most Recent Scoops
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Chimeric Therapeutics News & Media
Chimeric Therapeutics Secures $1.8 Million Advance on FY26 R&D Tax Incentive
02 Mar 2026 - Funding to support clinical trials and general working capital.Chimeric Therapeutics Secures $8.4 Million Funding to Advance CHM CDH17 Program
Chimeric Therapeutics Limited (ASX: CHM), a company focused on developing cell therapies to treat cancer, has announced it has secured firm commitments to raise $8.4 million. The funding comprises a $4.4 million placement to institutional, sophisticated, and professional investors and $4 million via a convertible note. Chimeric Therapeutics is developing innovative cell therapies to treatChimeric Therapeutics AGM Results and Leadership Changes - TipRanks.com
Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an update. Chimeric Therapeutics Ltd. announced the results of its Annual General Meeting, where all resolutio...Chimeric Secures $2.5M for R&D - Sharecafe
Chimeric Therapeutics (ASX:CHM) has received a $2.5 million advance from Endpoints Capital, leveraging its anticipated FY25 Research and Development Tax Incentive (RDTI). This funding agreement provides Chimeric with early access to a portion of its expected RDTI, secured against the future tax refund from the Australian Taxation Office. The funds will support Chimeric's clinical trial
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Chimeric Therapeutics
Sign Up For FreeTo access detailed company insights
Chimeric Therapeutics, founded in 2020 and based in Carlton, Australia, is a biotechnology company specializing in research and development of innovative cancer treatments. The company focuses on advancing novel therapeutic solutions through clinical trials and scientific research to address unmet medical needs in oncology. Chimeric Therapeutics op... Read More
